Could a common mood drug slow Parkinson's? new trial begins
NCT ID NCT06592014
First seen Nov 19, 2025 · Last updated May 21, 2026 · Updated 23 times
Summary
This study tests whether low-dose lithium can slow Parkinson's disease progression. About 35 people who have already completed a lithium study will take the drug for 24 more weeks. Researchers will use brain scans and blood tests to measure changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UBMD Neurology
Williamsville, New York, 14221, United States
Conditions
Explore the condition pages connected to this study.